ADVM — ADVERUM BIOTECHNOLOGIES INC

Ownership history in Squarepoint Ops LLC  ·  18 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in ADVERUM BIOTECHNOLOGIES INC (ADVM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2020 Q3)
Avg. % of fund
0.0%
First filed
2017 Q1
Last filed
2025 Q3
Quarters held
18
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 11,271 -10,381 -47.9% 0.00% $51K —
2025 Q2 REDUCED 21,652 -28,192 -56.6% 0.00% $47K —
2024 Q3 REDUCED 49,844 -59,134 -54.3% 0.00% $350K —
2024 Q2 ADDED 108,978 +81,808 +301.1% 0.00% $748K —
14 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)

Other funds also holding ADVM

As of 2025 Q3 — sorted by position size

BML Capital Management, LLC 3Y 12.68% Versant Venture Management, LLC 3Y 7Y 1.08% 5AM Venture Management, LLC 3Y 0.9% TCG Crossover Management, LLC 3Y 0.37% Frazier Life Sciences Management, L.P. 3Y 0.28% Pale Fire Capital SE 3Y 0.18% REGENERON PHARMACEUTICALS, INC. 0.12% Soleus Capital Management, L.P. 3Y 0.07% Quinn Opportunity Partners LLC 3Y 7Y 0.01% Waverly Advisors, LLC 3Y 7Y 0.01%
← Back to Squarepoint Ops LLC Holdings